Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE DaVita HealthCare Partners Inc.
DENVER, June 10, 2014 /PRNewswire/ -- DaVita HealthCare Partners Inc. (NYSE: DVA) (the "Company") today announced the pricing of $1.75 billion principal amount of 5.125% Senior Notes due 2024 (the "Senior Notes"). The offering is expected to close on June 13, 2014, subject to satisfaction of customary closing conditions.
The Company intends to use the net proceeds from the offering to repay, concurrently with the closing of the offering, a portion of its term loan borrowings under its senior secured credit facilities, and to pay fees and expenses related to the offering.
The Senior Notes are being offered pursuant to an effective registration statement filed with the Securities and Exchange Commission. Wells Fargo Securities, Barclays, BofA Merrill Lynch, Credit Suisse, Goldman, Sachs & Co., J.P. Morgan, Morgan Stanley and SunTrust Robinson Humphrey are acting as joint book-running managers for the offering. Credit Agricole CIB, Mitsubishi UFJ Securities, Scotiabank and SMBC Nikko are acting as co-managers for the offering.
The offering of Senior Notes is being made only by means of the prospectus supplement and accompanying prospectus. You may obtain copies of the prospectus supplement and accompanying prospectus from Wells Fargo Securities, LLC at (800) 326-5897 or firstname.lastname@example.org, Barclays Capital Inc. at (888) 603-5847 or Barclaysprospectus@ broadridge.com, BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attention: Prospectus Department, or email email@example.com, Credit Suisse Securities (USA) LLC at (800) 221-1037 or Newyork.firstname.lastname@example.org, Goldman, Sachs & Co. at (866) 471-2526 or email@example.com, J.P. Morgan Securities LLC at (800) 245-8812, Morgan Stanley & Co. LLC at (866) 718-1649 and SunTrust Robinson Humphrey, Inc. at (404) 926-5052. This communication shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
This release contains forward-looking statements within the meaning of the federal securities laws, including statements related to the anticipated offering and the intended use of proceeds from such offering. Factors that could impact these statements include the uncertainties associated with the risk factors set forth in our SEC filings, including our annual report on Form 10-K for the year ended December 31, 2013, our subsequent quarterly and annual reports, our current reports on Form 8-K and the registration statement filed on Form S-3 and the related prospectus supplement filed in connection with the offering of the Senior Notes. The forward-looking statements should be considered in light of these risks and uncertainties.
These risks and uncertainties include, but are not limited to, and are qualified in their entirety by reference to the full text of those risk factors in our SEC filings relating to:
We base our forward-looking statements on information currently available to us at the time of this release, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of changes in underlying factors, new information, future events or otherwise.
Contact: Jim Gustafson
DaVita HealthCare Partners Inc.
©2012 PR Newswire. All Rights Reserved.